SUMMARY
The article has presented the results of a marketing analysis of the domestic pharmaceutical market of anti-ulcer drugs and identified its main characteristics. This market segment is characterized by dependence on imports (78,79 % of range), the dominance of synthetic drugs (76,26 %). The market is the most represented preparations in tablet dosage forms (277 trade names, or 57,32 %). In addition, the uneven distribution of trade names on International Nonproprietary Names. In addition, notes the monopolization of the market by the number of presented trade names drugs both among imported and domestic drug manufacturers. It was established that during 2013-2015 the market observed a consistent trend to an increase in average purchasing and retail prices for anti-ulcer drugs, and in 2016 there was a positive to their decrease. On the whole it can be argued about the unavailability (Daver. = 0.93), anti-ulcer drugs for most of the population. At the same time, domestic products more accessible (Daver. = 0.96) than imported drugs (Daver. = 0.94). Most drugs have been available from the group of alginic acid, and the least – dekslansoprazol. The results of these studies emphasize the social and economic relevance of developing and implementing a national program of import substitution and compensation mechanisms consumption cost of medicines in Ukraine.